As of 2024-12-15, the EV/EBITDA ratio of Theraclion SA (ALTHE.PA) is -5.22. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ALTHE.PA's latest enterprise value is 13.37 mil EUR. ALTHE.PA's TTM EBITDA according to its financial statements is -2.56 mil EUR. Dividing these 2 quantities gives us the above ALTHE.PA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.8x - 13.8x | 11.4x |
| Forward P/E multiples | 9.4x - 13.2x | 10.7x |
| Fair Price | (0.43) - (0.64) | (0.52) |
| Upside | -211.7% - -266.9% | -236.6% |
| Date | EV/EBITDA |
| 2024-12-11 | -5.56 |
| 2024-12-10 | -5.58 |
| 2024-12-09 | -4.80 |
| 2024-12-06 | -4.86 |
| 2024-12-05 | -4.80 |
| 2024-12-04 | -4.89 |
| 2024-12-03 | -4.84 |
| 2024-12-02 | -4.70 |
| 2024-11-29 | -4.80 |
| 2024-11-28 | -4.30 |
| 2024-11-27 | -4.52 |
| 2024-11-26 | -4.17 |
| 2024-11-25 | -4.44 |
| 2024-11-22 | -4.91 |
| 2024-11-21 | -4.91 |
| 2024-11-20 | -4.44 |
| 2024-11-19 | -3.94 |
| 2024-11-18 | -4.46 |
| 2024-11-15 | -4.64 |
| 2024-11-14 | -4.64 |
| 2024-11-13 | -4.64 |
| 2024-11-12 | -4.75 |
| 2024-11-11 | -5.09 |
| 2024-11-08 | -5.07 |
| 2024-11-07 | -5.25 |
| 2024-11-06 | -5.16 |
| 2024-11-05 | -4.95 |
| 2024-11-04 | -4.98 |
| 2024-11-01 | -4.98 |
| 2024-10-31 | -5.11 |
| 2024-10-30 | -5.05 |
| 2024-10-29 | -5.13 |
| 2024-10-28 | -5.25 |
| 2024-10-25 | -5.13 |
| 2024-10-24 | -5.13 |
| 2024-10-23 | -5.14 |
| 2024-10-22 | -5.52 |
| 2024-10-21 | -5.49 |
| 2024-10-18 | -5.47 |
| 2024-10-17 | -5.40 |
| 2024-10-16 | -5.40 |
| 2024-10-15 | -5.47 |
| 2024-10-14 | -5.50 |
| 2024-10-11 | -5.52 |
| 2024-10-10 | -5.90 |
| 2024-10-09 | -5.83 |
| 2024-10-08 | -5.77 |
| 2024-10-07 | -5.88 |
| 2024-10-04 | -5.88 |
| 2024-10-03 | -5.70 |